Edithistory:DFV890
From EverybodyWiki Bios & Wiki
| oldid | date/time | username | edit summary |
|---|---|---|---|
| 1361893882 | 2026-06-30T18:34:00Z | Kowal2701 | [[WP:LLMPRV|Presumptive removal of LLM-generated content]], see [[Wikipedia:AI noticeboard/Archive 2#LLM edits by Noxoug1]]. Feel free to reinstate by following [[WP:LLMPRVOBJ|the procedures for disputing presumptive removal of LLM-generated content]]. |
| 1308417370 | 2025-08-29T10:04:50Z | Citation bot | Added article-number. Removed parameters. Some additions/deletions were parameter name changes. | [[:en:WP:UCB|Use this bot]]. [[:en:WP:DBUG|Report bugs]]. | Suggested by Abductive | [[Category:Tertiary alcohols]] | #UCB_Category 81/390 |
| 1298386575 | 2025-07-02T05:15:51Z | DMacks | |type= is an enum not free-text |
| 1296051510 | 2025-06-17T13:51:37Z | WikiCleanerBot | v2.05b - [[User:WikiCleanerBot#T23|Bot T23 CW#558]] - Fix errors for [[WP:WCW|CW project]] (Duplicated reference) |
| 1292635456 | 2025-05-28T01:27:45Z | Graeme Bartlett | added [[Category:Carboxamides]] using [[WP:HC|HotCat]] |
| 1292635029 | 2025-05-28T01:24:28Z | Graeme Bartlett | added [[Category:Indacenes]] using [[WP:HC|HotCat]] |
| 1292586620 | 2025-05-27T19:54:17Z | Boghog | ce |
| 1292586098 | 2025-05-27T19:51:00Z | Boghog | /* Mechanism of action */ more copyedit |
| 1292585451 | 2025-05-27T19:47:04Z | Boghog | made clear that DFV890targets the NLRP3 protein |
| 1292584666 | 2025-05-27T19:41:54Z | Boghog | /* top */ added missing identifier to drug infobox |
| 1292583778 | 2025-05-27T19:36:45Z | Boghog | per [[WP:HEAD]], sentence case for section headings |
| 1292583381 | 2025-05-27T19:34:21Z | Boghog | /* top */ copyedit to make accessible to a wide audience |
| 1292582327 | 2025-05-27T19:28:38Z | Boghog | /* Osteoarthritis */ typo |
| 1292582245 | 2025-05-27T19:28:09Z | Boghog | consistent citation formatting; combined repeated citationsn |
| 1292577936 | 2025-05-27T19:01:26Z | Innerstream | |
| 1292570625 | 2025-05-27T18:13:02Z | Davemck | rmv duplicate parm |
| 1292546715 | 2025-05-27T15:08:25Z | Noxoug1 | |
| 1292546678 | 2025-05-27T15:08:06Z | Noxoug1 | infobox |
| 1292546441 | 2025-05-27T15:06:13Z | Noxoug1 | Rescuing 2 sources and tagging 0 as dead.) #IABot (v2.0.9.5 |
| 1292546411 | 2025-05-27T15:05:59Z | Noxoug1 | |
| 1292546088 | 2025-05-27T15:03:27Z | Noxoug1 | infobox |
| 1292545716 | 2025-05-27T15:00:42Z | Citation bot | Altered date. Add: authors 1-1. Removed URL that duplicated identifier. Removed parameters. Some additions/deletions were parameter name changes. | [[:en:WP:UCB|Use this bot]]. [[:en:WP:DBUG|Report bugs]]. | Suggested by Noxoug1 | #UCB_webform |
| 1292545615 | 2025-05-27T15:00:05Z | Noxoug1 | |
| 1292544931 | 2025-05-27T14:54:50Z | Noxoug1 | |
| 1292544869 | 2025-05-27T14:54:23Z | Noxoug1 | /* References */ |
| 1292544807 | 2025-05-27T14:53:54Z | Noxoug1 | /* Osteoarthritis */ |
| 1292544758 | 2025-05-27T14:53:31Z | Noxoug1 | /* Osteoarthritis */ |
| 1292544690 | 2025-05-27T14:53:04Z | Noxoug1 | /* Osteoarthritis */ |
| 1292544635 | 2025-05-27T14:52:41Z | Noxoug1 | /* Osteoarthritis */ |
| 1292544591 | 2025-05-27T14:52:22Z | Noxoug1 | /* Clinical Trials */ |
| 1292544546 | 2025-05-27T14:52:01Z | Noxoug1 | /* COVID-19 */ |
| 1292544486 | 2025-05-27T14:51:38Z | Noxoug1 | /* COVID-19 */ |
| 1292544419 | 2025-05-27T14:51:23Z | Noxoug1 | /* COVID-19 */ |
| 1292544395 | 2025-05-27T14:51:06Z | Noxoug1 | /* COVID-19 */ |
| 1292544372 | 2025-05-27T14:50:52Z | Noxoug1 | /* Clinical Trials */ |
| 1292544339 | 2025-05-27T14:50:38Z | Noxoug1 | /* Development History */ |
| 1292544315 | 2025-05-27T14:50:25Z | Noxoug1 | /* Development History */ |
| 1292544291 | 2025-05-27T14:50:12Z | Noxoug1 | /* Development History */ |
| 1292544268 | 2025-05-27T14:49:59Z | Noxoug1 | /* Development History */ |
| 1292544238 | 2025-05-27T14:49:45Z | Noxoug1 | /* Development History */ |
| 1292544200 | 2025-05-27T14:49:28Z | Noxoug1 | /* Mechanism of Action */ |
| 1292544179 | 2025-05-27T14:49:17Z | Noxoug1 | /* Mechanism of Action */ |
| 1292544133 | 2025-05-27T14:48:54Z | Noxoug1 | /* Mechanism of Action */ |
| 1292544104 | 2025-05-27T14:48:41Z | Noxoug1 | /* Mechanism of Action */ |
| 1292544082 | 2025-05-27T14:48:29Z | Noxoug1 | /* Mechanism of Action */ |
| 1292544052 | 2025-05-27T14:48:15Z | Noxoug1 | |
| 1292544028 | 2025-05-27T14:48:04Z | Noxoug1 | |
| 1292543962 | 2025-05-27T14:47:29Z | Noxoug1 | |
| 1292543894 | 2025-05-27T14:46:54Z | Noxoug1 | [[WP:AES|←]]Created page with '{{in use}} '''DFV890''' is an investigational small-molecule oral drug under development by [[Novartis]] for conditions involving excessive [[NLRP3]] inflammasome activation, including [[COVID-19|COVID-19-associated acute respiratory distress syndrome]] (CARDS), [[osteoarthritis]], and [[myeloid]] diseases such as [[myelodysplastic syndromes]] (MDS) and [[chronic myelomonocytic leukemia]] (CMML).' |
